Latest news

10 October 2026

Genentech: One-year Phase III data for vamikibart in uveitic macular edema

Vamikibart showed sustained vision gains and reduced macular thickness at 52 weeks in MEERKAT and SANDCAT; FDA has accepted the BLA with a decision due by July 2027.
10 October 2026

Merck: BRUNELLO one-year data — remigromig non-inferior to ranibizumab in DME

Remigromig met non-inferiority for mean BCVA change versus monthly ranibizumab at one year in DME; higher rates of PDR-related adverse events and discontinuations were reported.
9 October 2026

Equinor and Shell partner on Bay du Nord; Shell takes 30% stake

Transaction supports maturation toward an early‑2027 investment decision; operator retains 70% and FPSO-based development in the Flemish Pass continues.
9 October 2026

EMA recommends Intervet's Bovilis Lumpyvax for lumpy skin disease

Live attenuated vaccine cuts clinical signs and viraemia from three weeks post‑vaccination and confers protection for one year; authorised under exceptional circumstances; side effects are uncommon.
9 October 2026

CVMP meeting highlights — 6–8 Oct 2026

Positive opinions for Bovilis Lumpyvax and Stemyca; Mirataz SPC updated for overdose effects; Vaxxitek MA extended one year; Vetmedin re‑examination concluded positive by majority.
9 October 2026

Arkema showcases battery material solutions at US Battery Show 2026

Highlights binders, PVDF and thermal/safety materials for EV and stationary batteries; 15% PVDF capacity expansion completed in June 2026; visit Booth #2714 Oct 12–15 in Detroit.
9 October 2026

Aurora delivers first pyrolysis bio-oil from Empyro

First load of pyrolysis bio-oil delivered to FrieslandCampina for co-firing in industrial steam boilers, partially replacing natural gas.
9 October 2026

Eli Lilly: Taltz plus Zepbound show broader immunometabolic biomarker changes in TOGETHER‑PsO

Combination therapy produced broader psoriasis-related and metabolic biomarker changes vs Taltz alone as early as Week 12, with greater reductions in inflammatory and neutrophil markers.
9 October 2026

Johnson & Johnson ICOTYDE delivers durable 2‑year plaque psoriasis results

Phase 3 data show sustained PASI90/PASI100 and IGA 0/1 responses to Week 112, durable itch improvement, and no new safety signals.
9 October 2026

Sinopec Beidou oil and gas field technology and terminal R&D project passes MIIT acceptance

MIIT accepted a 'one-stop' Beidou tech and terminal R&D demonstration for oil and gas that produced 8 product categories, 34 terminals and is deployed across 104 enterprises.
9 October 2026

Asahi Kasei Therapeutics doses first patient in Phase 2a trial of AIC468 for BK virus

First patient dosed in a randomized Phase 2a trial of AIC468, an antisense oligonucleotide targeting BK virus in adult kidney transplant recipients.
8 October 2026

Nouryon news and press releases

Regulatory clearance in China to supply a plant-based, water‑soluble pharmaceutical ingredient; India operations re-certified Great Place To Work for a second consecutive year.
8 October 2026

Genentech: FDA approves Tecentriq plus fluoropyrimidine and oxaliplatin as adjuvant for stage III dMMR colon cancer

FDA backs first adjuvant immunotherapy regimen for stage III dMMR colon cancer after ATOMIC showed a 50% reduction in recurrence or death with Tecentriq added to chemotherapy.
8 October 2026

Koch Technology Solutions and Alpek sign license for Suape PTA steam-reduction retrofit

License-backed retrofit to cut steam consumption, improve energy efficiency and competitiveness at the Suape PTA plant; moves to Process Design Package after a feasibility study.
8 October 2026

ProLogium unveils DCN third lithium‑ion transport mechanism (SFIE)

Introduces a Dynamic Coordination Network using a Superfluidized Inorganic Electrolyte to enable a third ion‑transport mode and fast‑charging automotive applications.
8 October 2026

Aptar expands pharma manufacturing in Mumbai

Adds local production of pMDI valves, breath‑actuated inhalation devices and multi dose nasal spray systems; site grows to 11,300 m² to improve regional supply resilience.
8 October 2026

BASF launches GLYTHERMIN® coolants for liquid‑cooled data centers

Propylene‑glycol heat‑transfer fluids for direct liquid cooling; DC PG25 is NVIDIA DSX Ready Coolant; BASF cites backward integration for supply reliability and corrosion protection tech.
8 October 2026

Rompetrol Rafinare to install 9.4 MW PV plant at Petromidia refinery

9.4 MW PV at Petromidia to supply >9,800 MWh/year for internal use, cut ~6,024 tCO2/year; project cost ~44 million lei with 14 million lei EU Modernization Fund grant; completion by 31 Dec 2028.
8 October 2026

QatarEnergy and Petrobras secure seven Ceará Basin exploration blocks

Seven deepwater exploration blocks in Brazil’s Ceará Basin (≈4,700 km²; 2,000–3,600 m depths) awarded in ANP’s 6th concession round; contracts expected H1 2027.
8 October 2026

Equinor gas discovery at Gullfaks South

Gas found at Gullfaks South: 0.5–1.6 million standard cubic metres of recoverable oil equivalents (3.3–10.3 million boe), drilled as a sidetrack to a production well.
8 October 2026

Bayer’s finerenone sNDA accepted by FDA for CKD without diabetes

FDA acceptance of finerenone sNDA for adults with CKD without diabetes follows Phase III FIND‑CKD showing slower eGFR decline and reduced cardio‑kidney events versus placebo.
8 October 2026

argenx discontinues Phase 3 UNITY trial of efgartigimod SC in Sjögren's disease

Independent Data Monitoring Committee advised stopping the trial for futility after an interim analysis; safety remained consistent and no new signals were seen.
8 October 2026

argenx: Phase 2 shows FB102 protects intestine in celiac disease

FB102, a CD122 inhibitor, met the primary histology endpoint (Vh:Cd change; p=0.0176) versus placebo and showed aligned symptom and inflammatory benefits with no new safety signals.
8 October 2026

Eni CCUS Holding: Douglas CCS — first offshore CO₂ transport and storage platform

New offshore hub will collect CO₂ from North West England and North Wales and route it via repurposed pipelines to depleted gas reservoirs; delivered in under 18 months; project ~50% complete.
8 October 2026

Arkema opens next-generation acrylic acid purification unit in Carling

New purification unit at Carling cuts energy use by 25% and site carbon intensity by 20%; nearly €150m investment, partly funded by France 2030 and NextGenerationEU.
8 October 2026

Vopak secures NSW endorsement for Port Botany SAF-capable expansion

NSW backing supports ~120,000 cbm storage increase at Port Botany with new tanks and pipelines, enabling SAF storage; project still requires FID and planning approvals.
8 October 2026

Siemens to digitalize GalpH2Park 100 MW renewable hydrogen plant

Deploys a digital twin-based Hydrogen Performance Suite for a 100 MW plant in Sines to boost scheduling and energy procurement; targets 15,000 t H2/yr and ~110,000 t CO2e avoided.
7 October 2026

Nouryon cleared to supply Cekol CMC-Na for China's drugmakers

China’s regulator approved a plant-based, water‑soluble CMC excipient for pharmaceutical manufacturing, enabling supply into China’s large drug production market.
7 October 2026

Toray's 150°C inverter test with heat‑resistant film capacitor

Prototype film capacitor with a 150°C dielectric ran stably in an inverter; thermal simulation suggests heat-dissipation structure could be halved, aiding lighter air‑cooled units.
7 October 2026

Aurubis expands Hamburg multimetal hub with automated pre‑processing facility

Automated sensor- and x‑ray-equipped plant to pre-process metal-bearing intermediates, improving valuation, safety and routing within the smelter network; due late 2028.